Navigation Links
Aratana Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/13/2013

aw; and our intention not to pay dividends.  These and other important factors discussed under the caption "Risk Factors" in the Company's most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, or SEC, , and our other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)
jdrumm@tiberend.com; (212) 375-2664Andrew Mielach (media)
amielach@tiberend.com; (212) 375-2694  

ARATANA THERAPEUTICS, INC.STATEMENT OF OPERATIONS(unaudited in thousands, except per share amounts) Three Months EndedSeptember 30,Nine Months EndedSeptember 30,2013201220132012Revenue$
-$
-$
-$
-Operating expensesResearch and development

3,2341,6587,8175,338General and administrative

1,4271,0653,9112,186Total operating expenses

4,6612,72311,7287,524Loss from operations(4,661)(2,723)(11,728)(7,524)Other income (expense)Interest income

2655112Interest expense

(80)-(182)-Other income

448145581Total other income (expense)

(10)8632493Net loss and comprehensive loss$
(4,671)$
(2,637)$
(11,404)$
(7,431)Unaccreted dividends on convertible preferred stock'/>"/>

SOURCE Aratana Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aratana to Participate in Leerink Swanns November Management Access Days
2. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
3. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
5. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
6. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
7. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
8. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
9. Aratana Therapeutics Drives Awareness of Pet Therapeutic Opportunity During "CVC Week" in Kansas City
10. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
11. Aratana Therapeutics names Wendy Yarno to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Pharmaceutical Research and Manufacturers of America,s (PhRMA) ... in the research and development (R&D) of new innovative ... all biopharmaceutical R&D spending – both public and private ... The new R&D numbers, the result of a recent ... newly released PhRMA 2015 Biopharmaceutical Research Industry ...
(Date:4/20/2015)... -- U.S. pharmacy cost increases for active employees and pre- and ... by 2016, according to an analysis by Aon Hewitt ... Aon plc (NYSE: AON ). Pharmacy cost ... percent in 2015 and will continue to rise to 10 ... rate of increase in 2017, with pharmacy costs rising by ...
(Date:4/20/2015)... 20, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today shared highlights of new ... Cancer Research (AACR) annual meeting. Halozyme also announced ... Phase 2 study in pancreatic cancer, Study 202, ... American Society of Clinical Oncology (ASCO). ...
Breaking Medicine Technology:PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5
... AMSTERDAM, July 12, 2011 Leading events organiser UBM ... announced that its pharmaceutical ingredients event, CPhI China 2011 and ... China for pharmaceutical machinery and equipment and BioPh China to ... 23rd at the SNIEC in Shanghai, experienced a 36% increase ...
... 12, 2011 Roche (SIX: RO, ROG; OTCQX: ... CALP ) today announced a co-marketing agreement ... for the NimbleGen SeqCap EZ Library solution-based capture ... aims to simplify high throughput targeted resequencing workflows ...
Cached Medicine Technology:China Pharma Events Attract Over 27,000 Visitors 2China Pharma Events Attract Over 27,000 Visitors 3Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 2Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 3
(Date:4/21/2015)... Invictus Medical has secured the ... for a second innovative technology aimed at making ... newborn infants’ cognitive development. , “This technology addresses ... have identified through extensive interviews and input from ... Invictus Medical’s Chief Technology Officer. “We believe this ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 “The warm ... SunGrubbies.com. “Doesn’t every mother want to look younger than her ... is the first line of defense. Signs of ... are the evidence of too much time spent in the ... only reason to cover up. The dangers of UV ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Heritage Woods ... host an Open House and Dine-and-Dash Spaghetti Dinner from ... The community, which is located in Centralia, Illinois, houses ... homes for low-income adults 55 and older. , Guests ... staff about supportive living options for seniors. After the ...
(Date:4/20/2015)... Church, VA (PRWEB) April 21, 2015 ... Sponsors and CMOs Speed Production and Improve Compliance , ... 3:00 p.m. EDT, http://www.fdanews.com/qualitybydesign , The life ... are forcing them to do more with less. ... sponsors and CMOs to finds ways to speed up ...
(Date:4/20/2015)... Reality show stars, food, fashion and fun for ... Michigan International Women’s Show, April 30 - May 3, ... to see and do from enjoying a makeover or ... said Beth Anderson, executive show manager of Southern Shows. ... from Randy Fenoli of ‘Say Yes to the Dress,’ ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3
... investigates the challenges that pen and paper workarounds ... of electronic health records. Understanding these challenges may ... health IT. Focusing on referrals by primary ... specialists back to the referring physician, "Paper Persistence, ...
... The American Society of Clinical Oncology (ASCO) Annual Meeting, ... for treating recurrent gliobastoma (GBM) has a favorable safety ... more than the current median survival rate. Patients ... Center, University of California, San Francisco and Columbia University, ...
... the most vulnerable group are the elderly. Writing in ... in New Zealand suggest that emergency response plans must ... regards to the personal and social resources they have ... University in Palmerston North, point out that elderly citizens ...
... the arteries is one of the leading causes of death. ... growth of fibrous plaques, which leads to narrowing or occlusion ... The persistence of the inflammatory reaction is due to a ... So-called dendritic cells are known to play a central role ...
... quality care for young people do not always provide the ... found. As our population ages and requires more healthcare, ... for the over 65s and implement programs to meet their ... director at St. Michael,s Hospital. The study, published in ...
... HealthDay Reporter , THURSDAY, June 2 (HealthDay News) -- The ... bacteria in Europe should serve as a red flag ... mutating and changing. They,re not necessarily becoming more severe, but ... attending physician in infectious diseases at North Shore University Hospital ...
Cached Medicine News:Health News:Paper and computer workarounds challenge but may improve health IT 2Health News:Paper and computer workarounds challenge but may improve health IT 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 4Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 5Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 6Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 7Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 8Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 9Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 10Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 11Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 12Health News:Helping the aged during natural disasters 2Health News:Fast track to vascular disease 2Health News:Fast track to vascular disease 3Health News:Not all hospitals treat elderly the same 2Health News:Deadly E. Coli Strain in Europe Should Serve as Warning, Experts Say 2Health News:Deadly E. Coli Strain in Europe Should Serve as Warning, Experts Say 3
Inquire...
20L...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: